Cardiac Rhythm Device Summit: Implantation, Management, and Follow Up 2024

Start

Thu, 20 Jun 2024, 09:00

End

Sat, 22 Jun 2024, 18:00

WebSite

https://iii.hm/cardiacrhythm2024

Venue:

Find Mayo Clinic On Social Media

Exhibit

Symposia

Workshops

Organiser

Sponsor

Course Description

The Cardiac Device Summit will provide an update on the indications, follow up, and management of cardiac rhythm technology, emphasizing clinical pearls. Hundreds of thousands of patients receive cardiac rhythm devices each year for brady or tachyarrhythmis and heart failure. In addition, the number of people who may benefit from an implantable cardioverter defibrillator (ICD) and/or cardiac resynchronization device (CRT) has substantially increased in the past decade. Evolving device technology has increased programming complexity, follow-up, and management.

Learning Objectives

Upon completion of this activity, participants should be able to:

describe the current indications for pacemaker, ICD, subcutaneous ICD, and resynchronization therapies

recognize upcoming technologies such as leadless and epicardial devices

interpret diagnostic material (electrocardiograms, impedance, radiography, and other sources) to troubleshoot suspected implantable device malfunction

discuss CIED related common issues such as management of device patients having MRI, radiation, infection and extract implantable devices

identify the current capabilities and roles of remote monitoring to manage patients with cardiovascular risk and disease; and, recognize precise cardiac anatomy to facilitate lead placement.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Intended Audience

The symposium is designed for cardiologists, internists, family practitioners, physician’s assistants and cardiovascular nurse practitioners and technologists caring for patients with cardiac rhythm management.